There are 14 resources available
Next generation neo-adjuvant and adjuvant trials in EGFR M+ and other oncogene-addicted lung cancer (excluding IO)
Presenter: Enriqueta Felip, ES
Session: Session 4 - Early EGFR M+ NSCLC
Resources:
Slides
Webcast
Role of IO in early and advanced stage EGFR M+ lung cancer
Presenter: Solange Peters, CH
Session: Session 5 - Facing the uncertainties
Resources:
Slides
Webcast
Biology and impact of co-mutations on management of EGFR M+ lung cancer
Presenter: Daniel S. W.Tan, SG
Session: Session 5 - Facing the uncertainties
Resources:
Slides
Webcast
Novel treatment approaches to EGFR M+ lung cancer
Presenter: James C.-H. Yang, TW
Session: Session 5 - Facing the uncertainties
Resources:
Slides
Webcast